| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.53 | 0.0002 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |